Genetic engineering and allogeneic optimization of V{delta}1 {gamma}{delta} CAR-T cells (ADI-270) for cancer immunotherapy
Genetic engineering has fundamentally transformed T cell–based therapies by enabling tumor targeting capability, improving their functionality, and facilitating allogeneic use. These strategies—originally developed in αβ chimeri…